RPG Life Sciences Limited (NSE:RPGLIFE)
India flag India · Delayed Price · Currency is INR
2,630.00
+23.80 (0.91%)
Nov 12, 2026, 3:30 PM IST

RPG Life Sciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,0921,1521,832876.6676.4514.8
Depreciation & Amortization
235.7212.3211.5164.5146.9148.5
Other Amortization
2.52.52.86.28.18.1
Loss (Gain) From Sale of Assets
0.9-0.1-12-0.17.8-
Asset Writedown & Restructuring Costs
91.691.6----
Loss (Gain) From Sale of Investments
-28.4-64.4-69.6-57.7-14.4-8.9
Provision & Write-off of Bad Debts
18.97.5-16.22750.9
Other Operating Activities
-216.9-325.3-909.8-2-32.115.2
Change in Accounts Receivable
-325.3-296.3-357.5-142.5-54248.1
Change in Inventory
-516.2-387.761.9-59.5-120.6-246.6
Change in Accounts Payable
70.5176.195.463.3192.6-19.1
Change in Other Net Operating Assets
131.9-2.9-60.367.892.5-13.5
Operating Cash Flow
557.2565778.6943.6908.2647.5
Operating Cash Flow Growth
30.19%-27.43%-17.49%3.90%40.26%11.12%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-667.3-653.6-360.3-692.3-327.3-239.5
Sale of Property, Plant & Equipment
--1,0951.50.8-
Investment in Securities
-719.1484.5-287.9-269.6-569.9-119.7
Other Investing Activities
1,2841,028-864.5168.9-161.712.6
Investing Cash Flow
-1,923858.4-418-791.5-1,058-346.6

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
-200----
Total Debt Issued
250200----
Short-Term Debt Repaid
-----2.7-3.1
Long-Term Debt Repaid
----0.1-6.6-7.7
Lease Payments
-----6.5-6.6
Total Debt Repaid
-1.8---0.1-9.3-10.8
Net Debt Issued (Repaid)
248.2200--0.1-9.3-10.8
Issuance of Common Stock
2,427-----
Common Dividends Paid
-396.9-396.9-264.6-198.5-158.8-119.1
Other Financing Activities
-23.6-8.9-6.2-4.5-3.1-5.2
Financing Cash Flow
2,264-205.8-270.8-203.1-171.2-135.1

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
-----0.1-
Net Cash Flow
898.21,21889.8-51-321.2165.8

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-110.1-88.6418.3251.3580.9408
Free Cash Flow Growth
--66.45%-56.74%42.38%-18.01%
Free Cash Flow Margin
-1.44%-1.25%6.40%4.32%11.33%9.27%
Free Cash Flow Per Share
-6.75-5.3625.2915.1935.1224.67
Levered Free Cash Flow
-107.18-161.7325.59222.04487.99350.38
Unlevered Free Cash Flow
-93.99-156.14329.46224.85489.93353.63
Free Cash Flow After Leases
-110.1-88.6418.3251.3574.4401.4

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
23.68.96.24.53.15.2
Cash Income Tax Paid
356.3372.2527.5293.1252.3188.5
Change in Working Capital
-639.1-510.8-260.5-70.9110.5-31.1